No Evidence That Patents Slow Access to Vaccines
This commentary was originally published in STAT on April 13, 2021
At this point in the exhausting and deadly Covid-19 pandemic, people around the globe are giving thanks for the multiple vaccines that have been produced and authorized in record time. All governments now share the goal of quick and worldwide vaccination.
To reach this goal, many are latching onto the idea of suspending intellectual property rights for Covid-19 vaccines and medicines, including more than 400 health, labor, religious, and other groups. Late last year, the governments of India and South Africa petitioned the World Trade Organization to waive patent protections for Covid-19 therapies.